Pro and Con
Pro: Routine Use of Embolic Protection Devices in Transcatheter Aortic Valve Replacement Should Be Considered

https://doi.org/10.1053/j.jvca.2017.07.016Get rights and content

Section snippets

Embolic Protection Devices

Embolic protection devices have been developed as a potential method to mitigate cerebral embolization and the associated neurologic sequelae during TAVR. Four distinct devices have been tested in prospective studies and randomized, controlled trials.22, 42, 46 The common feature of all current devices involves percutaneous deployment of a porous membrane apparatus at the level of the aortic arch or great vessels, which either filters or deflects emboli while allowing for unrestricted blood

Discussion

The results of the aforementioned trials are encouraging and demonstrate that embolic phenomena occurring during TAVR can be attenuated, as seen with DW-MRI, with a potential reduction in neurologic insult. The MISTRAL-C and CLEAN-TAVI trials have highlighted the ability of these devices to reduce cerebral embolism, and as newer technologies develop, it is conceivable that embolic protection devices will play an important role in further maximizing the safety of TAVR. It is well established

Conclusion

Major stroke after TAVR has devastating consequences and has been described by some as a “fate worse than death.”66 With the advancement of technique and design of delivery systems and valves, it is evident that the success of TAVR will only be enhanced by the application of risk-minimization strategies to provide outcomes superior to SAVR. Although there are multiple approaches to help minimize the risk of stroke in TAVR due to its variable causes, the mechanical advantage of embolic filter

First page preview

First page preview
Click to open first page preview

References (67)

  • A. Ghanem et al.

    Risk and fate of cerebral embolism after transfemoral aortic valve implantation: A prospective pilot study with diffusion-weighted magnetic resonance imaging

    J Am Coll Cardiol

    (2010)
  • M. Arnold et al.

    Embolic cerebral insults after transapical aortic valve implantation detected by magnetic resonance imaging

    JACC Cardiovasc Interv

    (2010)
  • M. Pagnesi et al.

    Silent cerebral injury after transcatheter aortic valve implantation and the preventive role of embolic protection devices: A systematic review and meta-analysis

    Int J Cardiol

    (2016)
  • V.H. Thourani et al.

    The future of transaortic transcatheter aortic valve replacement

    JACC Cardiovasc Interv

    (2016)
  • H. Omran et al.

    Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: A prospective, randomised study

    Lancet

    (2003)
  • J. Rodes-Cabau et al.

    Feasibility and exploratory efficacy evaluation of the Embrella Embolic Deflector system for the prevention of cerebral emboli in patients undergoing transcatheter aortic valve replacement: The PROTAVI-C pilot study

    JACC Cardiovasc Interv

    (2014)
  • N.M. Van Mieghem et al.

    Incidence and predictors of debris embolizing to the brain during transcatheter aortic valve implantation

    JACC Cardiovasc Interv

    (2015)
  • O. Abdul-Jawad Altisent et al.

    Embolic protection devices during TAVI: Current evidence and uncertainties

    Rev Esp Cardiol (Engl Ed)

    (2016)
  • S.M. O’Brien et al.

    The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 2—Isolated valve surgery

    Ann Thorac Surg

    (2009)
  • A.C. Anyanwu et al.

    Unrealistic expectations arising from mortality data reported in the cardiothoracic journals

    J Thorac Cardiovasc Surg

    (2002)
  • E.J. Veen et al.

    The accuracy of complications documented in a prospective complication registry

    J Surg Res

    (2012)
  • A.J. Lansky et al.

    Neurologic complications of unprotected transcatheter aortic valve implantation (from the Neuro-TAVI Trial)

    Am J Cardiol

    (2016)
  • S.E. Vermeer et al.

    Silent brain infarcts: A systematic review

    Lancet Neurol

    (2007)
  • S.C. Knipp et al.

    Cognitive outcomes three years after coronary artery bypass surgery: Relation to diffusion-weighted magnetic resonance imaging

    Ann Thorac Surg

    (2008)
  • E. Stabile et al.

    Cerebral embolic lesions detected with diffusion-weighted magnetic resonance imaging following carotid artery stenting: A meta-analysis of 8 studies comparing filter cerebral protection and proximal balloon occlusion

    JACC Cardiovasc Interv

    (2014)
  • J.S. Lawton

    A fate worse than death

    J Thorac Cardiovasc Surg

    (2016)
  • T.G. Gleason et al.

    The risk and extent of neurologic events are equivalent for high-risk patients treated with transcatheter or surgical aortic valve replacement

    J Thorac Cardiovasc Surg

    (2016)
  • G.W. Eveborn et al.

    The evolving epidemiology of valvular aortic stenosis. The Tromso study

    Heart

    (2013)
  • R. Rosenhek et al.

    Natural history of very severe aortic stenosis

    Circulation

    (2010)
  • J. Turina et al.

    Spontaneous course of aortic valve disease

    Eur Heart J

    (1987)
  • M. Lindroos et al.

    Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample

    J Am Coll Cardiol

    (1998)
  • C.R. Smith et al.

    Transcatheter versus surgical aortic-valve replacement in high-risk patients

    N Engl J Med

    (2011)
  • S. Arora et al.

    Transcatheter aortic valve replacement: Comprehensive review and present status

    Tex Heart Inst J

    (2017)
  • Cited by (4)

    View full text